Substituted fused bicyclic amines as modulators of chemokine receptor activity
申请人:Batt G. Douglas
公开号:US20050197373A1
公开(公告)日:2005-09-08
The present application describes modulators of CCR3 of formula (Ia) and (Ib):
or pharmaceutically acceptable salt forms thereof, wherein Z, R
1
, R
2
, R
3
, R
4
, R
5
, R
5
′, R
6
, a, b, c, d, and u are as defined herein. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis using said modulators are disclosed.
N-substituted heterocyclic amines as modulators of chemokine receptor activity
申请人:——
公开号:US20040067935A1
公开(公告)日:2004-04-08
The present application describes modulators of chemokine receptors of formula (I):
1
or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
本申请描述了化学式(I)的趋化因子受体调节剂或其药用盐形式,可用于预防哮喘和其他过敏性疾病。
Chiral Bifunctional Phosphine-Carboxylate Ligands for Palladium(0)-Catalyzed Enantioselective C−H Arylation
作者:Lei Yang、Markus Neuburger、Olivier Baudoin
DOI:10.1002/anie.201712061
日期:2018.1.26
Previous enantioselective Pd0‐catalyzed C−H activation reactions proceeding via the concerted metalation‐deprotonation mechanism employed either a chiral ancillary ligand, a chiral base, or a bimolecular mixture thereof. This study describes the development of new chiral bifunctional ligands based on a binaphthyl scaffold which incorporates both a phosphine and a carboxylic acid moiety. The optimal
Palladium catalyzed N–H bond insertion and intramolecular cyclization cascade: the divergent synthesis of heterocyclics
作者:Dong Ding、Gang Liu、Guangyang Xu、Jian Li、Guoping Wang、Jiangtao Sun
DOI:10.1039/c4ob00001c
日期:——
A palladium-catalyzed one-pot procedure of N–H insertion and Heck cyclization/base promoted cyclization has been developed.
一种钯催化的一锅法N-H插入和Heck环化/碱促进环化方法已经被开发出来。
Ortho-substituted anthranilic acid amides and their use as medicaments
申请人:——
公开号:US20040102441A1
公开(公告)日:2004-05-27
Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.